Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (653) Hereditary Angioedema
...CenterWatch: Clinical Trials in Category (653) Hereditary Angioedema Hereditary Angioedema State • Arkansas • California • Colorado • Florida • Georgia • Illinois • Iowa • Maryland • Missouri • New Jersey • New York • North ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (653), Hereditary Angioedema
...CenterWatch: New Medical Therapies in Disease Category (653), Hereditary Angioedema Hereditary Angioedema Patient Medical Areas • Dermatology/Plastic Surgery • Immunology/Infectious Diseases August 25, 2008 Dyax issued positive ...
View Page

3.  Study Posting (4668) Trial #113982, Hereditary Angioedema, Mineola, NY
...Study Posting (4668) Trial #113982, Hereditary Angioedema, Mineola, NY Trial Information Volunteers needed for acute Hereditary Angioedema Attack research studies. The purpose is to determine the safety and efficacy (how well it ...
View Page

4.  Study Posting (4668) Trial #91324, Hereditary Angioedema, Mineola, NY
...Study Posting (4668) Trial #91324, Hereditary Angioedema, Mineola, NY Trial Information The purpose of this study is to determine the safety of an experimental drug, when used to try to treat angioedema attacks. Inclusion Criteria: • Patient must be 10 years of age or older • Patient must have ...
View Page

5.  Study Posting (5455) Trial #160850, Hereditary Angioedema, Québec, QC, USA
...Study Posting (5455) Trial #160850, Hereditary Angioedema, Québec, QC, USA Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

6.  Study Posting (5455) Trial #160845, Hereditary Angioedema, Ottowa, ON, USA
...Study Posting (5455) Trial #160845, Hereditary Angioedema, Ottowa, ON, USA Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

7.  Study Posting (5455) Trial #158729, Hereditary Angioedema, San Antonio   , TX
...Study Posting (5455) Trial #158729, Hereditary Angioedema, San Antonio   , TX Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

8.  Study Posting (5455) Trial #158730, Hereditary Angioedema, Dallas, TX
...Study Posting (5455) Trial #158730, Hereditary Angioedema, Dallas, TX Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

9.  Study Posting (5455) Trial #158806, Hereditary Angioedema, Hershey, PA
...Study Posting (5455) Trial #158806, Hereditary Angioedema, Hershey, PA Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

10.  Study Posting (5455) Trial #158733, Hereditary Angioedema, Bethlehem, PA
...Study Posting (5455) Trial #158733, Hereditary Angioedema, Bethlehem, PA Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

11.  Study Posting (5455) Trial #160849, Hereditary Angioedema, Tulsa, OK
...Study Posting (5455) Trial #160849, Hereditary Angioedema, Tulsa, OK Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

12.  Study Posting (5455) Trial #160843, Hereditary Angioedema, Columbus, OH
...Study Posting (5455) Trial #160843, Hereditary Angioedema, Columbus, OH Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

13.  Study Posting (5455) Trial #158808, Hereditary Angioedema, Asheville, NC
...Study Posting (5455) Trial #158808, Hereditary Angioedema, Asheville, NC Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

14.  Study Posting (5455) Trial #160844, Hereditary Angioedema, New York, NY
...Study Posting (5455) Trial #160844, Hereditary Angioedema, New York, NY Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

15.  Study Posting (5455) Trial #158807, Hereditary Angioedema, Edison, NJ
...Study Posting (5455) Trial #158807, Hereditary Angioedema, Edison, NJ Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

16.  Study Posting (5455) Trial #160846, Hereditary Angioedema, St. Louis, MO
...Study Posting (5455) Trial #160846, Hereditary Angioedema, St. Louis, MO Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

17.  Study Posting (5455) Trial #158731, Hereditary Angioedema, Chevy Chase, MD
...Study Posting (5455) Trial #158731, Hereditary Angioedema, Chevy Chase, MD Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

18.  Study Posting (5455) Trial #160847, Hereditary Angioedema, Iowa City, IA
...Study Posting (5455) Trial #160847, Hereditary Angioedema, Iowa City, IA Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

19.  Study Posting (5455) Trial #160851, Hereditary Angioedema, Chicago, IL
...Study Posting (5455) Trial #160851, Hereditary Angioedema, Chicago, IL Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page

20.  Study Posting (5455) Trial #158728, Hereditary Angioedema, Atlanta, GA
...Study Posting (5455) Trial #158728, Hereditary Angioedema, Atlanta, GA Trial Information This study is being conducted to evaluate the efficacy of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE). To be eligible for the study, you must be at least 18 years old ...
View Page